Health Care Provider Medical Advisory: Product change to Shingrix
What is happening? The Ministry of Health’s publicly funded vaccine for herpes zoster will be changing to a 2-dose Shingrix series when the 1-dose Zostavax supply expires and runs out in October 2020. Eligibility for publicly funded product remains at age 65-70. Those who turned or will turn 71 in Read more…